Head and Neck Cancer

Perspectives on Tobacco Cessation Among Patients With HNC, Clinicians

By

Jessica Nye, PhD

Publish Date September 22, 2021

In-depth qualitative interviews with oncology clinicians and current and former smokers reveal some common perspectives on smoking and cessation.

2008 to 2017 Saw Drop in Malignant Brain Tumor Incidence

Publish Date August 31, 2021

Incidence among children, adolescents increased 0.5 to 0.7 percent; malignant tumor incidence highest for males, non-Hispanic Whites

Multifocality Appears to Increase Risk of Recurrence in Papillary Thyroid Carcinoma

By

Leah Lawrence

Publish Date August 31, 2021

The risk of recurrence varied by patient age, tumor size, and number of foci.

Gemcitabine Plus Cisplatin Improves Overall Survival in Advanced Nasopharyngeal Carcinoma

By

Sucharita Mistry, PhD

Publish Date August 20, 2021

Gemcitabine plus cisplatin reduced the risk of death by 28%.

Sodium Thiosulfate Appears to Decrease Ototoxic Effects of Platinum Chemo Without Compromising Efficacy

By

Leah Lawrence

Publish Date August 12, 2021

More studies are needed to confirm if there is an effect on survival, according to researchers.

Personalized Radiotherapy Shields May Effectively Protect Healthy Tissue During RT for Prostate, Oral Cancer

By

Bryant Furlow

Publish Date August 6, 2021

Early results demonstrate the potential of personalized 3D-printed shields for protecting healthy GI tissue in patients undergoing radiotherapy for prostate cancer.

Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors

By

Jonathan Goodman, MPhil

Publish Date August 5, 2021

Response endpoints were not strongly correlated with overall survival at the trial level.

Patient Perception of Outcomes Associated With Psychosocial Function After Reconstruction for Head and Neck Cancer

By

Vicki Moore, PhD

Publish Date July 28, 2021

Survey-based study determined the association between patients’ perception of aesthetic outcome and psychosocial function after undergoing ablation with this complex procedure.

Taste, Smell Dysfunction May Persist After HNSCC Treatment for Longer Than Survivors Anticipate

By

Bette Weinstein Kaplan

Publish Date July 19, 2021

Researchers sought to determine when and to what extent survivors of head and neck squamous cell cancers would recover their senses of taste and smell.

Survey Identified Risk Factors Linked to Voice, Speech Impairment in Survivors of Oropharyngeal Cancer

By

Vicki Moore, PhD

Publish Date May 19, 2021

A survey of long-term survivors of oropharyngeal cancer identified those with higher risk of experiencing voice and speech impairment.